Carboplatin (AUC 6)

DRUG2 trials

Sponsors

Eli Lilly and Company, Fundación GECP

Conditions

Carcinoma, Non-Small-Cell LungNon Small Cell Lung CancerRespiratory Tract Neoplasm

Phase 2

A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT01160744

Eli Lilly and CompanyCarcinoma, Non-Small-Cell Lung

Start: 2010-09-30End: 2018-04-30Updated: 2019-09-13

Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)

Not yet recruitingNCT07247786

Fundación GECPNon Small Cell Lung Cancer, Respiratory Tract Neoplasm

Start: 2026-03-15End: 2031-12-30Target: 68Updated: 2025-12-30